Chemical structure of TAK-071

low α- M1R positive allosteric modulator

7.5 mg+ PO QD in Ph. II for Parkinson’s

from eval. of M1R PAMs w/ low cooperativity

British Journal of Clinical Pharmacology

Takeda Pharmaceutical, Cambridge, USA

The Takeda brain-penetrant M1R positive allosteric modulator (PAM), TAK-071, was optimized for lower cooperativity (α) with the native ligand to theoretically reduce the side effect of diarrhea from M1R…


 this content is exclusive to
Premium members

Unlock this content with a Premium membership to read it now.